Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • lovenlong
    Member
    • Jan 2013
    • 16

    Confused about adjacent somatic SNVs within a 100bp window

    Hi all,

    I'm calling somatic SNVs with the matched tumor/normal-pairs, and the called candidates overlapped among multiple callers were further visualized with the IGV and analyzed manually.
    Theoretically, the vast majority of true positive SNVs sould be singletons within a window of 100 bp. However, I found several adjacent high quality candidates were not singletons and emanated from the same reads or read-pairs. I was confused by this kind of adjacent SNVs.

    What can explain this kind of high quality non-singleton SNVs ?

    I don't know if they were false positives resulted from mapping/aligment errors.
    At the preprocessing stage, I removed reads containing Ns, trimmed adaptors and low quality bases (Q30). Then, only paired reads were used and aligned to ref with bwa default settings. When calling SNVs, only reads with mapping quality score > 30 (MAPQ>30) were counted, and threshold for calling an SNV was alternate reads >= 3.

    Best regards.
    Attached Files
    Last edited by lovenlong; 01-02-2014, 07:01 AM.
  • m_two
    Member
    • Mar 2010
    • 50

    #2
    You may need to filter strand specific errors from your data. In addition, some indels can result in alignment anomalies that result in multiple SNPs appearing in close proximity near the ends of the aligned portion of the reads containing the indel.

    Many tools have filters in place to address these artifacts. Varscan includes a filtering tool that you may be able to apply to your data. See http://tvap.genome.wustl.edu/tools/varscan/.

    If you see somatic mutations with support on both strands in close proximity you may want to refer to this manuscript:



    An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancersNature Genetics 45, 970–976 (2013) doi:10.1038/ng.2702

    "...throughout cancer genomes APOBEC-mediated mutagenesis is pervasive and correlates with APOBEC mRNA levels. Mutation clusters in whole-genome and exome data sets conformed to the stringent criteria indicative of an APOBEC mutation pattern. "
    Last edited by m_two; 01-02-2014, 09:46 AM.

    Comment

    • lovenlong
      Member
      • Jan 2013
      • 16

      #3
      Hi, m_two
      Thanks for your reply.

      Actually, my samples were not real somatic tissues, but were pooled of 100 rice plant individuals following mutagenesis. The theoretical variant allele frequency would be very low (<1%), and we thought it would help to improve calling accuracy of these heterozygous SNVs by using the matched tumor-normal pairs.

      As marked in the attached figure, the Tumor_1_bwa.bam and Tumor_2_bwa.bam was the pool of mutagenized generation 1 and 2 respectively,the corresponding wild-type generation 1 and 2 was Normal_1_bwa.bam and Normal_2_bwa.bam. My wild-type was a pure rice cultivar which had been self-crossing at least 15 generations.

      Due to low effective coverage, I merged the two generations of pools respectively, and called "somatics" with muTect, Strelka and Varscan2. My analysis pipeline was as follows:
      1.calling somatic: (MAPQ≥30, Base_Q≥30)
      Clean reads > bwa mapping > merged_BAMs > calling somatic with different callers > filtering
      Clean reads > Stampy mapping > merged_BAMs > calling somatic with different callers > filtering

      2. Eliminate mapping errors by combining calls of bwa and stampy.
      calls_of_bwa_callerA + calls_of_stampy_callerA > overlapped SNVs of callerA
      calls_of_bwa_callerB + calls_of_stampy_callerB > overlapped SNVs of callerB
      ...

      muTect_passed_overlapped = 519
      Strelka_passed_overlapped =55
      Varscan2_passed_overlapped = 60

      3. Finding concordant overlapped_SNVs among mutliple callers
      muTect_call = Varsc_call =29 SNVs, muTect_call = Strelka_call =43 SNVs, Varsc_call = Strelka_call =23, 3_callers_overlapped=20.

      4. Implement hard filtration of SNVs
      (1) No more than 1 ALT read or read pair has additional mismatch/gap;
      (2) No more than 3 additional mismatches/gaps exist within 50 bp either side of ALT site;
      (3) ALT reads maximum MAPQ > 40;
      (4) When ALT reads ≥ 4, they should not emanate exclusively from one strand;
      (5) At least 2 mismatches or gaps are not in the 10 bp beginning or end of ALT reads;
      (6) Mismatches or gaps are not at the beginning or end of homopolymers or SSRs (n>4)

      Finally, 35 SNVs called by at least 2 callers were selected for validation.
      I'm not sure if my analysis workflow was correct.
      I would be very grateful if any body could give me some suggestions.

      Best regards.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        Today, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Today, 11:10 AM
      0 responses
      7 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-13-2026, 10:26 AM
      0 responses
      29 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-09-2026, 10:04 AM
      0 responses
      38 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-08-2026, 10:08 AM
      0 responses
      25 views
      0 reactions
      Last Post SEQadmin2  
      Working...